Inozyme Pharma Raises $49 Million in a Series A Financing to Develop Therapies for Rare Diseases Affecting Soft Tissues and Bone

VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.